Nick Smith

Nick Smith has served as our Chief Financial Officer since November 2022 and has served as our Chief Business Officer since September 2021. Mr. Smith also served as a member of our board of directors from July 2023 through October 2023. Prior to joining us, Mr. Smith served in various roles at Aptinyx Inc., a CNS-focused biopharmaceutical company, from March 2017 until September 2021, including Vice President, Investor Relations and Corporate Development from March 2021 to September 2021; Senior Director, Corporate Development and Investor Relations from March 2019 to March 2021; and Director, Corporate Development from March 2017 to March 2019. Mr. Smith received a BA in accounting and finance from North Central College.